Imaprelimab Biosimilar Monoclonal Antibody (MCAM) for Research

Cat No.: GMP-Bios-ab-266

Pre-Made Imaprelimab biosimilar, Whole mAb, Anti-MCAM Antibody: Anti-CD146/HEMCAM/METCAM8/MelCAM therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.



Order Information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. →
Catalog No. Package List Price(In USD) Discount off Discount Price
GMP-Bios-ab-266-1mg 1mg 3090

Size: 1mg | 10mg | 100mg



Product Details

Products Name (INN Index) Pre-Made Imaprelimab biosimilar, Whole mAb, Anti-MCAM Antibody: Anti-CD146/HEMCAM/METCAM8/MelCAM therapeutic antibody
INN Name Imaprelimab
TargetMCAM
FormatWhole mAb
DerivationHumanized
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-I
Est. StatusDiscontinued
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2017
Year Recommended2018
CompaniesNeotope Biosciences;Onclave Therapeutics;Prothena;Prothena Corporation
Conditions Approvedna
Conditions Activena
Conditions DiscontinuedCancer;Inflammation;Psoriasis
Development Techna



About target - MCAM

1. Protein Cell surface glycoprotein MUC18

2. Gene MCAM

3. Organism Homo sapiens (Human)

Function
Plays a role in cell adhesion, and in cohesion of the endothelial monolayer at intercellular junctions in vascular tissue. Its expression may allow melanoma cells to interact with cellular elements of the vascular system, thereby enhancing hematogeneous tumor spread. Could be an adhesion molecule active in neural crest cells during embryonic development. Acts as surface receptor that triggers tyrosine phosphorylation of FYN and PTK2/FAK1, and a transient increase in the intracellular calcium concentration.